Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of Pentoxifylline, Ursodiol, and Empagliflozin on Fatty Liver of Patients With Type-2 Diabetes

NCT04910178 is registered in ClinicalTrials.gov with Asmaa Abdelfattah Elsayed as lead sponsor.

NCT NCT04910178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04910178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of Pentoxifylline, Ursodiol, and Empagliflozin on Fatty Liver of Patients With Type-2 Diabetes
Lead sponsor
Asmaa Abdelfattah Elsayed
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2020
Completion date
December 30, 2021
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2, nafld